Russian Patent Office (Rospatent)
now providing ISRs for U.S. inventors at low cost
February 2, 2012
U.S. inventors and companies filing PCT
patent applications may have a new
opportunity to save money and obtain
expanded search results for
biotechnology. Rospatent and the
USPTO finally hammered out electronic
document delivery issues and the
long-awaited partnership between the two
offices has finally gone online (USPTO
Press Release). Effective
January 10, 2012 Rospatent is now will
act as an available International
Searching Authority (ISA) and
International Preliminary Examining
Authority (IPEA) for international
applications filed with the USPTO as the
Receiving Office (RO/US), under the
Patent Cooperation Treaty (PCT).
The cost savings for
designating Rospatent as the ISA are substantial over the other available
options to U.S. applicants. See our comparison chart below (USPTO
Fee Schedule):

Fast Tracking
Applications using Rospatent ISR
Russia is a signatory
to the Patent Prosecution Highway (Rospatent
PPH page). If you receive a positive International Search Report
(must file a Demand) from Rospatent that
indicates your invention is free of prior art you may file a no-cost
petition in the U.S. to accelerate your application out of turn.
Another Search
Option for U.S. Inventors
Although there are
currently fourteen (14) International Search Authorities (full
list), only five (5) are available to U.S. Inventors (U.S., Europe,
Australia, Korea and Russia) as the initial search authority.
Additional ISAs are available for supplementary examination (which is
infrequently used).
Subject Matter
that will be Searched
Korea (KIPO) has been a
favorite option for technology transfer departments because it
is relatively inexpensive (currently $1,101) and fast. However, under PCT
Rule 39, KIPO will not search methods for treatment of the human or animal
body by surgery or therapy, as well as diagnostic methods (Rule
39.1(iv), under Article 17(2)(a)(i)).
Rospatent has
indicated it will search everything in Rule 39.1 except methods for
treatment of the human or animal body by surgery or therapy
expressly under the PCT
provisions. However, Rospatent will
search PCT subject matter it otherwise excluded under Rule 39.1 under Russia's
national grant procedure. This will likely include searching relating to various
aspects of biotechnology making Rospatent an ideal search authority for the
biotech field (see subject matter patentable in Russia below).
|
Rule 39.1 Areas
|
U.S.
|
Europe
|
Australia
|
Korea
|
Russia
|
|
(i) science/math theories
|
û
|
û
|
û
|
û
|
ü
|
|
(ii) plant/animal varieties
|
û
|
û
|
û
|
û
|
ü |
|
(iii) business methods/games
|
û
|
û
|
û
|
û
|
ü |
|
(iv) methods of surgery/therapy and diagnostics
|
û
|
û
|
û
|
û
|
û
|
|
(v) presentation of information
|
û
|
û
|
û
|
û
|
ü |
|
(vi) computer programs
|
û
|
û
|
û
|
ü |
ü |
U.S., EPO, Australia, Korea and Russia - will still search all subject
matter which is searched under their national patent grant procedure.
Therefore, most aspects of biotech are searched by the U.S. and EPO and the
U.S. will search virtually everything else but under its own guidelines.
Australia has been criticized as unduely burdensome and highly restrictive
in its searches. Accordingly, Australia is infrequently designated as
an International Search Authority.
Subject Matter Patentable in Russia
According to the Civil Code of the Russian Federation (as of Dec. 1, 2007),
Part IV,
Section IV, Article 1350(1) provides patent protection for a
technical solution in any area related to a product (including a device,
substance, microorganism strain, cell culture of plants or animals) or
method (process of affecting a material object using material means).
Article 1350(5)
expressly excludes the following from patentability in Russia:
-
discoveries;
-
scientific theories and mathematical methods;
-
proposals concerning solely the outward appearance of manufactured
articles and intended to satisfy aesthetic requirements;
-
rules and methods of games and for intellectual or business
activity;
-
computer programs;
-
ideas on presentation of information.
In
addition, the following may be excluded from patent protection: varieties of plants, breeds of animals and integrated circuit layouts.
Thus, Rospatent will search in its ISR subject matter it would otherwise
deem unpatentable in its own jurisdiction.
Conclusion:
Many
companies and universities have had standing instructions to use KIPO as the
ISA. Although KIPO may still be a well-advised choice, Rospatent may
provide expanded searching of biotechnology at a lower cost and still
provide an opportunity to accelerate the examination in the U.S. using the
Patent Prosecution Highway.
|